| Name |
Endoxan 1000 mg prašak za otopinu za injekciju/infuziju |
| Marketing Authorisation Number |
HR-H-857890693 |
| Active Substance |
ciklofosfamid hidrat |
| Composition |
jedna bočica sadrži 1000 mg ciklofosfamida u obliku ciklofosfamid hidrata |
| Pharmaceutical Form |
prašak za otopinu za injekciju/infuziju |
| Manufacturer |
Baxter Oncology GmbH, Halle (Westfalen), Njemačka |
| Marketing Authorisation Holder |
Baxter d.o.o., Letališka cesta 29A, Ljubljana, Slovenija |
| Marketing Authorisation Date |
26.04.2019 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/281 |
| Registration Number |
381-12-01/30-19-10 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
L01AA01 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
